Full Text View
Tabular View
No Study Results Posted
Related Studies
Re-Exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients
This study is ongoing, but not recruiting participants.
Study NCT00675103   Information provided by Savient Pharmaceuticals
First Received: May 6, 2008   Last Updated: October 27, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Treatment Failure Gout
Additional conditions recognized in this trial
Gout
More general conditions related to this trial
Arthritis
Genetic Diseases, Inborn
Joint Diseases
Metabolic Diseases
Metabolism, Inborn Errors
Musculoskeletal Diseases
Purine-Pyrimidine Metabolism, Inborn Errors
Rheumatic Diseases
Interventions listed in this trial
pegloticase 8 mg i.v.
Sponsors listed in this trial
Savient Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services